StudyFinder

MT2013-09C : Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for the Treatment of Hematological Diseases

Status: Recruiting

This is a treatment protocol for an unrelated umbilical cord blood transplant (UCBT) using a myeloablative preparative regimen for the treatment of hematological diseases, including, but not limited to acute leukemias. There is no research element except the collection of routine clinical data.

I'm interested

Age: Not specified
Healthy Volunteers:
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• up to 55 years old
• see link to clinicaltrials.gov for inclusion criteria specific to each type of leukemia
Exclusion Criteria:

• Radiation Oncology will evaluate all patients who have had previous radiation therapy
• pregnant or breastfeeding
• HIV positive
• study staff will review additional exclusion criteria
Interventions:

Drug: Cyclophosphamide, Drug: Cyclosporine A, Drug: Fludarabine, Drug: Mycophenylate mofetil, Radiation: Total Body Irradiation, Biological: Umbilical cord blood

Conditions:

Cancer

Keywords:

Clinics and Surgery Center (CSC), Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia

Contact(s): Timothy Krepski - tkrepsk1@fairview.org
Principal Investigator: Margaret MacMillan, MD
Phase: NA
IRB Number: 1305M34181
System ID: 15529
See this study on ClinicalTrials.gov

Back